X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-03-16 | MYO | Getz Heather C | Dir | P - Purchase | $0.70 | +20,000 | 131,754 | +18% | +$13,972 | ||||||
2026-03-13 | MYO | Kirk Thomas F | Dir | P - Purchase | $0.71 | +72,000 | 553,857 | +15% | +$51,113 | ||||||
2026-03-12 | MYO | Getz Heather C | Dir | P - Purchase | $0.73 | +70,000 | 111,754 | +168% | +$50,960 | ||||||
| M | 2025-11-20 | MYO | Kirk Thomas F | Dir | P - Purchase | $0.72 | +7,437 | 481,857 | +2% | +$5,355 | |||||
| M | 2025-11-18 | MYO | Crowley Thomas Aloysius Jr. | Dir | P - Purchase | $0.74 | +4,385 | 76,227 | +6% | +$3,233 | |||||
2025-08-25 | MYO | Kirk Thomas F | Dir | P - Purchase | $1.15 | +50,000 | 474,420 | +12% | +$57,500 | ||||||
2025-08-18 | MYO | Kirk Thomas F | Dir | P - Purchase | $1.10 | +50,000 | 424,420 | +13% | +$55,000 | ||||||
2025-08-15 | MYO | Gudonis Paul R | CEO | P - Purchase | $0.95 | +50,000 | 1,259,013 | +4% | +$47,295 | ||||||
| M | 2025-05-14 | MYO | Kirk Thomas F | Dir | P - Purchase | $3.25 | +38,767 | 344,700 | +13% | +$125,993 | |||||
2025-05-15 | MYO | Gudonis Paul R | CEO | P - Purchase | $3.22 | +30,000 | 1,051,671 | +3% | +$96,612 | ||||||
2025-05-12 | MYO | Kirk Thomas F | Dir | P - Purchase | $3.35 | +50,000 | 305,933 | +20% | +$167,500 | ||||||
| A | 2025-03-14 | MYO | Mitchell Micah | Chief Commercial Officer | S - Sale | $5.16 | -48,000 | 140,269 | -25% | -$247,565 | |||||
2025-03-13 | MYO | Kirk Thomas F | Dir | P - Purchase | $5.00 | +7,400 | 255,933 | +3% | +$37,000 | ||||||
| A | 2025-03-14 | MYO | Mitchell Micah | Chief Commercial Officer | S - Sale | $5.16 | -48,000 | 140,572 | -25% | -$247,565 | |||||
2025-03-14 | MYO | Mitchell Micah | Chief Commercial Officer | S - Sale | $5.16 | -48,000 | 140,572 | -25% | -$247,565 | ||||||
2025-03-12 | MYO | Kovelman Harry | Chief Medical Officer | S - Sale | $5.50 | -30,000 | 96,477 | -24% | -$165,018 | ||||||
2024-09-05 | MYO | Kovelman Harry | Chief Medical Officer | S - Sale | $3.76 | -6,700 | 123,556 | -5% | -$25,183 | ||||||
2024-09-03 | MYO | Kovelman Harry | Chief Medical Officer | S - Sale | $4.01 | -2,029 | 130,256 | -2% | -$8,140 | ||||||
2024-05-29 | MYO | Kirk Thomas F | Dir | P - Purchase | $3.50 | +50,000 | 236,499 | +27% | +$175,000 | ||||||
2024-05-15 | MYO | Kovelman Harry | Chief Medical Officer | S - Sale | $3.69 | -35,426 | 98,009 | -27% | -$130,839 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |